Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the potential for meaningful therapeutic gains, principally in ailments where conventional therapies have proven inadequate. However, this is to consider the significant financial expenditure associated with CPI stem cell t